SELENBP1 and lung carcinoma: It is presumed that there are other mechanisms besides epigenetic changes suppressing the expression of SELENBP1, because previous reports showed that downregulation of SELENBP1 is not related to promoter methylation or gene deletion in colon and lung carcinomas [7,19].